DCF Advisers
DCF Advisers reported 91 stocks worth $337M in its 13F filing for Q3 2026, filed Nov 4, 2026. Its largest holdings are MU (20.9%), GOOG (5.5%) and AMD (5.3%). Compared with Q2 2026, the fund opened new positions in TEVA, SNY and IBIT, added to MRVL, VRTX and CRVS and trimmed MU, AMZN and ARGX.
Latest filing: what DCF Advisers did in Q3 2026
vs Q2 2026- Teva Pharmaceutica$8.6M
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MU Micron Technology Inc | $70.3M | 20.9% | 66K | −34K (−34%) | 8 of 8 | |
| 2 | ![]() GOOG Alphabet Inc | $18.4M | 5.5% | 54K | No change | 8 of 8 | |
| 3 | ![]() AMD Advanced Micro Devices Inc | $17.7M | 5.3% | 29K | No change | 8 of 8 | |
| 4 | ![]() AMZN Amazon Com Inc | $13.7M | 4.1% | 55K | −4,250 (−7%) | 8 of 8 | |
| 5 | CYBIN INC | $12.3M | 3.7% | 1M | −432K (−30%) | 6 of 8 | |
| 6 | ![]() ARGX Argenx SE | $11.2M | 3.3% | 12K | −2,500 (−18%) | 8 of 8 | |
| 7 | ![]() TEVA Teva Pharmaceutical Industries Ltd | $8.1M | 2.4% | 206K | New position | 1 of 8 | |
| 8 | ![]() MRVL Marvell Technology Inc | $7.9M | 2.4% | 30K | +2,500 (+9%) | 8 of 8 | |
| 9 | ![]() VRTX Vertex Pharmaceuticals I | $7.9M | 2.4% | 15K | +3,650 (+32%) | 4 of 8 | |
| 10 | ![]() IAU Ishares Gold TR | $7.8M | 2.3% | 100K | No change | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | $8.6M | 255K |
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() QQQ Invesco Qqq TR | Put | $67.5M | 91K | −101,800 |
![]() SPY Spdr S&P 500 ETF TR | Put | $21.4M | 28K | +3,000 |
![]() MU Micron Technology Inc | Call | $8.5M | 8,000 | −4,500 |
![]() IVV Ishares TR | Put | $3.8M | 5,000 | +5,000 |
![]() BHVN Biohaven Ltd | Call | $2.3M | 170K | +35,000 |
🔒 Free account: see all 13.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 4, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →DCF Advisers 13F FAQ
What does DCF Advisers own?
DCF Advisers reported 91 stocks worth $337M in its 13F filing for Q3 2026, filed Nov 4, 2026. Its largest holdings are MU (20.9%), GOOG (5.5%) and AMD (5.3%). The table above lists every position in the filing (the top 10 without an account).
What did DCF Advisers buy and sell in Q3 2026?
Compared with Q2 2026: 12 new positions, 25 added to, 28 trimmed and 1 sold out. New positions include TEVA, SNY and IBIT.
When will DCF Advisers file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is DCF Advisers's portfolio worth?
The Q3 2026 filing reports $337M in US stocks ($444M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























